FTO and acute myeloid leukemia: Moreover, another study indicated that R-2-hydroxyglutarate produced at high levels by mutant isocitrate dehydrogenase 1/2 enzymes exhibited anticancer effects by suppressing FTO activity, thereby increasing m6A levels in acute myeloid leukemia (AML) cells 134.